Full View

Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 …

A Karampeazis, A Voutsina, J Souglakos… - Cancer, 2013 - Wiley Online Library
BACKGROUND In this superiority study, pemetrexed was compared with erlotinib in pre‐
treated patients with metastatic non–small cell lung cancer (NSCLC). METHODS Patients …
被引用次数：146 相关文章
ACNP Full Text

Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 …

A Karampeazis, A Voutsina, J Souglakos… - Cancer, 2013 - europepmc.org
Background In this superiority study, pemetrexed was compared with erlotinib in pre-treated
patients with metastatic non-small cell lung cancer (NSCLC). Methods Patients with stage …
ACNP Full Text

Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 …

A Karampeazis, A Voutsina, J Souglakos… - Cancer, 2013 - infona.pl
BACKGROUND In this superiority study, pemetrexed was compared with erlotinib in pre‐
treated patients with metastatic non–small cell lung cancer (NSCLC). METHODS Patients …
ACNP Full Text

[引用][C] Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized …

A KARAMPEAZIS, A VOUTSINA, S AGELAKI… - Cancer, 2013 - pascal-francis.inist.fr
Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung
Cancer: A Hellenic Oncology Research Group (HORG) Randomized Phase 3 Study CNRS …
ACNP Full Text

Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 …

A Karampeazis, A Voutsina, J Souglakos… - Cancer, 2013 - pubmed.ncbi.nlm.nih.gov
Background In this superiority study, pemetrexed was compared with erlotinib in pre-treated
patients with metastatic non-small cell lung cancer (NSCLC). Methods Patients with stage …
ACNP Full Text

[引用][C] Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase …

A Karampeazis, A Voutsina, J Souglakos… - Cancer, 2013 - cir.nii.ac.jp
Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer:
A Hellenic Oncology Research Group (HORG) randomized phase 3 study | CiNii Research …
ACNP Full Text

[引用][C] Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized …

A KARAMPEAZIS, A VOUTSINA, J SOUGLAKOS… - Cancer, 2013 - Wiley-Blackwell